Background Coronavirus disease 2019 (COVID-19) is a disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), first detected in China in December, 2019. …

Because of their potent anti-inflammatory properties, corticosteroids have been used for
decades to treat many diseases, including rheumatic diseases. They are frequently used in …

Purpose Previously published guidelines provide comprehensive recommendations for
detecting and preventing healthcare-associated infections (HAIs). The intent of this document is …

Background: Sepsis is a serious and often fatal clinical syndrome, resulting from infection.
Information on patient demographics, risk factors, and infections leading to sepsis is needed to …

Background Data on medium-term outcomes in indivduals with myocarditis after mRNA
COVID-19 vaccination are scarce. We aimed to assess clinical outcomes and quality of life at …

Rationale: Pulmonary nontuberculous mycobacteria (NTM) disease is a chronic, nonreportable
illness, making it difficult to monitor. Although recent studies suggest an increasing …

Introduction More than 93,000 cases of coronavirus disease (COVID-19) have been reported
worldwide. We describe the epidemiology, clinical course, and virologic characteristics of …

Asthma is a disease with distinct phenotypes that have implications for both prognosis and
therapy. Epidemiologic studies have demonstrated an association between asthma and …

Mycobacterium abscessus is often resistant to multiple antimicrobial drugs, and data supporting
effective drugs or dosing regimens are limited. To better identify treatment approaches …

Objective:To describe pathogen distribution and rates for central-line–associated bloodstream
infections (CLABSIs) from different acute-care locations during 2011–2017 to inform …